Applicant, as named in the Orange Book
Fresenius Kabi Usa
Part of Fresenius SE & Co. KGaA
Company and ticker: cliffwatch mapping, checked against SEC EDGAR
Next listed expiry: Naropin on 28 Nov 2026. 10 products with live protection, 29 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Naropin NDA 020533 · 11 strengths ropivacaine hydrochloride | 28 Nov 2026 patent |
| Levothyroxine Sodium NDA 202231 · 3 strengths levothyroxine sodium | 3 Oct 2032 patent |
| Dilaudid NDA 019034 · 5 strengths hydromorphone hydrochloride | 12 Mar 2034 patent |
| Dilaudid-Hp NDA 019034 hydromorphone hydrochloride | 12 Mar 2034 patent |
| Morphine Sulfate NDA 204223 · 3 strengths morphine sulfate | 12 Mar 2034 patent |
| Kabiven In Plastic Container NDA 200656 · 4 strengths amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil | 3 May 2036 patent |
| Perikabiven In Plastic Container NDA 200656 · 3 strengths amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil | 3 May 2036 patent |
| Levothyroxine Sodium NDA 210632 · 3 strengths levothyroxine sodium | 1 Dec 2036 patent |
| Potassium Phosphates In 0.9% Sodium Chloride NDA 212832 · 2 strengths potassium phosphate, dibasic; potassium phosphate, monobasic | 12 Oct 2041 patent |
| Epinephrine NDA 215425 epinephrine | 17 Jan 2045 patent |
Recent events
- Calcium Gluconate · Generic approved · ANDA 217891, CiplaApproved 17 Sep 2026Detected 25 Oct 2026
- Xylocaine Preservative Free · Generic approved · ANDA 220071, Viwit PharmApproved 19 Mar 2026Detected 25 Oct 2026
- Diprivan · Generic approved · ANDA 217945, Emerge BioscienceApproved 2 Dec 2025Detected 25 Oct 2026
- Diprivan · Generic approved · ANDA 220857, AdaptisApproved 14 Jul 2026Detected 25 Oct 2026
- Magnesium Sulfate · Generic approved · ANDA 217461, AdaptisApproved 9 Jul 2026Detected 25 Oct 2026
- Sensorcaine · Generic approved · ANDA 220493, AdaptisApproved 22 Apr 2026Detected 25 Oct 2026
- Xylocaine Viscous · Generic approved · ANDA 218676, QuagenApproved 20 Mar 2026Detected 25 Oct 2026
- Naropin · Enters 12-month window basis: patentListed date 28 Nov 2026Detected 24 Oct 2026
- Naropin · Enters 12-month window basis: patentListed date 28 Nov 2026Detected 24 Oct 2026
Products without listed protection (29)
| Drug | Earliest generic entry |
|---|---|
| Atropine Sulfate NDA 209260 atropine sulfate | open now no listed protection |
| Calcium Gluconate NDA 208418 · 3 strengths calcium gluconate | open now no listed protection |
| Diprivan NDA 019627 propofol | open now no listed protection |
| Glucagon NDA 201849 · 2 strengths glucagon hydrochloride | open now no listed protection |
| Glycophos NDA 220381 · 2 strengths sodium glycerophosphate | open now no listed protection |
| Glycopyrrolate NDA 214919 glycopyrrolate | open now no listed protection |
| Heparin Sodium NDA 017651 heparin sodium | open now no listed protection |
| Heparin Sodium NDA 017029 · 4 strengths heparin sodium | open now no listed protection |
| Heparin Sodium 25,000 Units In Dextrose 5% NDA 017029 · 2 strengths heparin sodium | open now no listed protection |
| Heparin Sodium 25,000 Units In Sodium Chloride 0.45% NDA 017029 · 2 strengths heparin sodium | open now no listed protection |
| Heparin Sodium In Plastic Container NDA 017029 · 4 strengths heparin sodium | open now no listed protection |
| Heparin Sodium Preservative Free NDA 017029 · 2 strengths heparin sodium | open now no listed protection |
| Indomethacin NDA 022536 indomethacin | open now no listed protection |
| Magnesium Sulfate NDA 019316 · 4 strengths magnesium sulfate | open now no listed protection |
| Moxifloxacin Hydrochloride NDA 205572 moxifloxacin hydrochloride | open now no listed protection |
| Nebupent NDA 019887 pentamidine isethionate | open now no listed protection |
| Neostigmine Methylsulfate NDA 203629 · 3 strengths neostigmine methylsulfate | open now no listed protection |
| Nesacaine NDA 009435 chloroprocaine hydrochloride | open now no listed protection |
| Nesacaine-Mpf NDA 009435 · 2 strengths chloroprocaine hydrochloride | open now no listed protection |
| Omegaven NDA 210589 · 2 strengths fish oil triglycerides | open now no listed protection |
| Oxytocin NDA 018248 · 3 strengths oxytocin | open now no listed protection |
| Pentam NDA 019264 pentamidine isethionate | open now no listed protection |
| Potassium Phosphates NDA 212832 · 3 strengths potassium phosphate, dibasic; potassium phosphate, monobasic | open now no listed protection |
| Rocuronium Bromide NDA 217472 · 2 strengths rocuronium bromide | open now no listed protection |
| Sensorcaine NDA 018304 · 3 strengths bupivacaine hydrochloride | open now no listed protection |
| Sensorcaine NDA 018304 · 2 strengths bupivacaine hydrochloride; epinephrine bitartrate | open now no listed protection |
| Smoflipid 20% NDA 207648 · 4 strengths fish oil; medium chain triglycerides; olive oil; soybean oil | open now no listed protection |
| Xylocaine NDA 006488 · 4 strengths lidocaine hydrochloride | open now no listed protection |
| Xylocaine W/ Epinephrine NDA 006488 · 6 strengths epinephrine; lidocaine hydrochloride | open now no listed protection |